Monday, November 25, 2019 2:13:33 PM
Recent EVOK News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/06/2024 09:31:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 12:10:38 PM
- Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI® • GlobeNewswire Inc. • 10/28/2024 11:00:00 AM
- Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting • GlobeNewswire Inc. • 10/23/2024 12:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/22/2024 09:09:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/22/2024 09:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2024 01:00:32 PM
- Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors • GlobeNewswire Inc. • 10/22/2024 12:30:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 08:15:06 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/01/2024 08:53:00 PM
- Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion • GlobeNewswire Inc. • 10/01/2024 12:30:18 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/27/2024 09:11:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 09:08:06 PM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 09/20/2024 11:28:39 PM
- Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments • GlobeNewswire Inc. • 09/19/2024 06:20:38 PM
- Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference • GlobeNewswire Inc. • 09/09/2024 12:30:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/09/2024 04:15:04 AM
- Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 01:20:55 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/29/2024 08:16:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 11:00:08 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/13/2024 09:01:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:20:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 12:15:18 PM
- Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 12:00:03 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM